PerkinElmer, Inc. (PKI) And Procognia Limited To Offer Breakthrough Protein Array Platform
10/19/2005 5:12:28 PM
MAIDENHEAD, England & BOSTON--(BUSINESS WIRE)--Dec. 15, 2004--
PerkinElmer, Inc. (NYSE: PKI), a global leader in health sciences, and Procognia, a leading developer of innovative and transformational technologies in the field of proteomics, today announced an exclusive distribution and co-marketing agreement to deliver the only complete solution for high-throughput and high-resolution analysis of the glycosylation of proteins. Procognia's U-c fingerprint lectin array-based platform is being combined with PerkinElmer's advanced instrumentation, the Protein Array Workstation(TM) and the recently introduced ProScanArray(TM) HT, to offer the industry's first high-throughput, high-resolution glycoanalysis capability. Certain scientific estimates indicate that more than 60% of critical biological functions involve glycosylated proteins. This new technology will drive significant advancements in the understanding of protein function and structure.
comments powered by